鴻偉亞洲(08191.HK):Haitong Global Investment SPC III同意豁免公司悉數償付票據項下應付金額的責任
格隆匯8月17日丨鴻偉亞洲(08191.HK)發佈公吿,於2018年8月10日,該公司(作為發行人)與Haitong Global Investment SPC III(認購人)訂立認購協議,據此,該公司已同意發行最多為1億港元的有抵押及有擔保票據。
於本公佈日期,公司已與認購人訂立豁免函件,據此,認購人同意(其中包括)豁免公司悉數償付票據項下應付金額的責任,直至2021年9月6日為止,以待商討進一步延後還款日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.